Kyphon Preparing IDE Submission For Spinal Bone Cement Filler, IPO
This article was originally published in The Gray Sheet
Executive Summary
Kyphon plans to submit an investigational device exemption application to FDA later this year for an acrylic bone cement filler material to treat spinal fractures